Maravai Lifesciences Holdings Inc Capital Reinvestment Ratio
Maravai Lifesciences Holdings Inc capital reinvestment ratio. Maravai Lifesciences Holdings Inc (MRVI) has a Capital Reinvestment Ratio of 0.09x as of June 2026, meaning it reinvests 0% of its operating cash flow ($3.99 Million) in capital expenditures ($370.00K). Check MRVI capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Maravai Lifesciences Holdings Inc (2019–2024)
Capital reinvestment ratio of Maravai Lifesciences Holdings Inc from 2019 to 2024. This chart tracks Maravai Lifesciences Holdings Inc's Capital Reinvestment Ratio across 6 annual periods. Also explore Maravai Lifesciences Holdings Inc (MRVI) equity growth momentum to track the company's year-over-year net asset growth rate.
Maravai Lifesciences Holdings Inc Capital Reinvestment Ratio by Year (2019–2024)
Maravai Lifesciences Holdings Inc capital reinvestment ratio by year from 2019 to 2024. For the full cash flow conversion analysis, see Maravai Lifesciences Holdings Inc (MRVI) cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 3.97x | $7.46 Million | $29.66 Million | ▲ +665.0% |
| 2023 | 0.52x | $126.22 Million | $65.55 Million | ▲ +1528.8% |
| 2022 | 0.03x | $535.98 Million | $17.09 Million | ▼ -20.9% |
| 2021 | 0.04x | $368.57 Million | $14.85 Million | ▼ -75.9% |
| 2020 | 0.17x | $152.19 Million | $25.41 Million | ▼ -76.5% |
| 2019 | 0.71x | $24.11 Million | $17.15 Million | — |